Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.51 USD | +5.03% | +13.27% | -28.75% |
May. 20 | InfuSystem Approves $20 Million Share Buyback Plan -- Shares Rise After Hours | MT |
May. 20 | Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021. | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Sales forecast by analysts have been recently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 63.09 times its estimated earnings per share for the ongoing year.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-28.75% | 152M | C- | ||
-7.38% | 181B | C+ | ||
-0.46% | 108B | C | ||
-6.98% | 66.12B | A | ||
+2.65% | 50.65B | B- | ||
+5.27% | 43.11B | B- | ||
+6.01% | 40.74B | B+ | ||
+19.92% | 31.6B | B | ||
+15.75% | 25.56B | A- | ||
-7.00% | 24.16B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- INFU Stock
- Ratings InfuSystem Holdings, Inc.